Millennium Management’s Epizyme, Inc EPZM Stock Holding History

Millennium Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50,000	Closed	-$543K	–	6698
2020 Q4	$543K	Buy	+50,000	New	+$617K	﹤0.01%	4127
2017 Q2	–	Sell	-15,000	Closed	-$257K	–	4007
2017 Q1	$257K	Buy	+15,000	New	+$200K	﹤0.01%	3113

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Millennium Management's EPZM Position: Q3 2022 in Review

Millennium Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 1,548,767 shares — an estimated $2.28M sold.

Millennium Management first reported a position in EPZM in Q1 2014 and held it in 31 quarters. The position peaked at $22M in Q1 2019. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Millennium Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Millennium Management sold 1,548,767 Epizyme, Inc shares in Q3 2022, an estimated $2.28M.
Millennium Management first reported a position in Epizyme, Inc in Q1 2014 and held it in 31 quarters.
Millennium Management's Epizyme, Inc position peaked at $22M in Q1 2019.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Millennium Management's 13F filing for Q3 2022, filed 14 Nov 2022.